NHS Framework Agreement for Branded Medicines – National
A Contract Award Notice
by NHS ENGLAND
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- 190M-194M
- Sector
- HEALTH
- Published
- 27 Oct 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points
1 buyer
- NHS England Leeds
37 suppliers
- Accord Devon
- Pfizer Kent
- Aspen Pharmacare Berkshire
- Mylan Barnet
- Medac Pharma Stirling
- Ipsen Slough
- Bayer Reading
- Morningside Pharmaeuticals Northampton
- Sandoz Camberley
- Ul Global Pharma Watford
- Teva Castleford
- Day Lewis Medical Surrey
- Novartis Pharmaceuticals London
- Ferring Pharmaceuticals West Drayton
- Dexcel Pharma Daventry
- Gedeon Richter Maida Vale
- Chiesi Manchester
- Pharmasure Watford
- Astellas Pharma Surrey
- Nordic Pharma Theale
- Napp Pharmaceuticals Cambridge
- Martindale Pharma Essex
- Takeda London
- Kent Pharma Heathrow
- Glenmark Pharmaceuticals Europe Watford
- Tillomed Laboratories Luton
- Wockhardt Wrexham
- Zentiva Pharma London
- Qdem Pharmaceuticals Cambridge
- Aventis Pharma Berkshire
- Tetris Pharma Northampton
- Ridge Pharma Reading
- Merck Serono Feltham
- Flynn Pharma County Dublin
- Aspire Pharma Surrey
- Theramex HQ London
- Orifarm Essex
Description
NHS Framework Agreement for Branded Medicines – National Annual Category Tender and National Tender
Lot Division
1 | CM/PHR/20/5610/01 – NHS Framework Agreement for Branded Medicines – National Cat
CM/PHR/20/5610/01 – NHS Framework Agreement for Branded Medicines – National Category TenderPeriod of framework: 1 November 2021 to 31 October 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months |
2 | CM/PHR/20/5610/02 – NHS Framework Agreement for Branded Medicines – National Ten
CM/PHR/20/5610/02 – NHS Framework Agreement for Branded Medicines – National TenderPeriod of framework: 1 November 2021 to 30 April 2023 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 18months |
Award Detail
1 | Accord (Devon)
|
2 | Pfizer (Kent)
|
3 | Aspen Pharmacare (Berkshire)
|
4 | Mylan (Barnet)
|
5 | Medac Pharma (Stirling)
|
6 | Ipsen (Slough)
|
7 | Bayer (Reading)
|
8 | Morningside Pharmaeuticals (Northampton)
|
9 | Sandoz (Camberley)
|
10 | Ul Global Pharma (Watford)
|
11 | Teva (Castleford)
|
12 | Day Lewis Medical (Surrey)
|
13 | Novartis Pharmaceuticals (London)
|
14 | Ferring Pharmaceuticals (West Drayton)
|
15 | Dexcel Pharma (Daventry)
|
16 | Gedeon Richter (Maida Vale)
|
17 | Chiesi (Manchester)
|
18 | Pharmasure (Watford)
|
19 | Astellas Pharma (Surrey)
|
20 | Nordic Pharma (Theale)
|
21 | Napp Pharmaceuticals (Cambridge)
|
22 | Accord (Devon)
|
23 | Martindale Pharma (Essex)
|
24 | Takeda (London)
|
25 | Pfizer (Kent)
|
26 | Kent Pharma (Heathrow)
|
27 | Glenmark Pharmaceuticals Europe (Watford)
|
28 | Tillomed Laboratories (Luton)
|
29 | Medac Pharma (Stirling)
|
30 | Wockhardt (Wrexham)
|
31 | Morningside Pharmaeuticals (Northampton)
|
32 | Zentiva Pharma (London)
|
33 | Sandoz (Camberley)
|
34 | Ul Global Pharma (Watford)
|
35 | Qdem Pharmaceuticals (Cambridge)
|
36 | Day Lewis Medical (Surrey)
|
37 | Aventis Pharma (Berkshire)
|
38 | Tetris Pharma (Northampton)
|
39 | Ferring Pharmaceuticals (West Drayton)
|
40 | Ridge Pharma (Reading)
|
41 | Merck Serono (Feltham)
|
42 | Flynn Pharma (None)
|
43 | Gedeon Richter (Maida Vale)
|
44 | Aspire Pharma (Surrey)
|
45 | Pharmasure (Watford)
|
46 | Theramex HQ (London)
|
47 | Orifarm (Essex)
|
Award Criteria
price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-02b648
- FTS 026946-2021